{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:25Z","timestamp":1761178465606,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.canrad.2015.06.011","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T12:41:59Z","timestamp":1440852119000},"page":"610-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Suivi apr\u00e8s radioth\u00e9rapie d\u2019un cancer du canal anal"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-4695","authenticated-orcid":false,"given":"N.","family":"Meillan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Peiffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2015.06.011_bib0230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","author":"Jemal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canrad.2015.06.011_bib0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0959-8049(02)00377-5","article-title":"Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin\u00a0C in locally advanced anal carcinomas. Results of a phase\u00a0II study of the European Organization for Research and Treatment of Cancer","volume":"39","author":"Bosset","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2015.06.011_bib0240","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0245","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03\u00a0Trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0250","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT\u00a0II): a randomised, phase\u00a03, open-label, 2\u00d72\u00a0factorial trial","volume":"14","author":"James","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1470-2045(13)70121-9","article-title":"ACT\u00a0II: treatment of anal cancer comes full circle","volume":"14","author":"Willett","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0260","doi-asserted-by":"crossref","first-page":"iii10","DOI":"10.1093\/annonc\/mdu159","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0265","doi-asserted-by":"crossref","first-page":"106","DOI":"10.6004\/jnccn.2010.0007","article-title":"NCCN clinical practice guidelines in oncology. Anal carcinoma","volume":"8","author":"Engstrom","year":"2010","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.canrad.2015.06.011_bib0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1259\/bjr\/96187638","article-title":"Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation","volume":"81","author":"Koh","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0275","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0360-3016(89)90519-1","article-title":"Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242\u00a0cases","volume":"17","author":"Schlienger","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"year":"2010","series-title":"Common terminology criteria for adverse events (CTCAE). Version 4. 0 [document sur Internet]","author":"Anon","key":"10.1016\/j.canrad.2015.06.011_bib0280"},{"year":"2015","series-title":"Cooperative Group Common Toxicity Criteria [informations sur Internet]","author":"Anon","key":"10.1016\/j.canrad.2015.06.011_bib0285"},{"key":"10.1016\/j.canrad.2015.06.011_bib0290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1748-717X-9-113","article-title":"Efficacy and toxicity of chemoradiation in patients with anal cancer-a retrospective analysis","volume":"9","author":"Koerber","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0295","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0761-8425(06)72018-6","article-title":"Complications pulmonaires des traitements du cancer bronchique","volume":"23","author":"Bonniaud","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.canrad.2015.06.011_bib0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-13-39","article-title":"Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches","volume":"13","author":"Matsuno","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.canrad.2015.06.011_bib0305","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000079633","article-title":"Interstitial lung disease induced by drugs and radiation","volume":"71","author":"Camus","year":"2004","journal-title":"Respiration"},{"key":"10.1016\/j.canrad.2015.06.011_bib0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nephro.2004.12.001","article-title":"Toxicit\u00e9 r\u00e9nale des anticanc\u00e9reux","volume":"1","author":"Isnard-Bagnis","year":"2005","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.canrad.2015.06.011_bib0315","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00330-010-1980-7","article-title":"Anal carcinomas: the role of endoanal ultrasound and magnetic resonance imaging in staging, response evaluation and follow-up","volume":"21","author":"Parikh","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0320","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00464-008-0130-7","article-title":"Accuracy of endoanal ultrasound in the follow-up assessment for squamous cell carcinoma of the anal canal treated with radiochemotherapy","volume":"23","author":"Martellucci","year":"2009","journal-title":"Surg Endosc"},{"key":"10.1016\/j.canrad.2015.06.011_bib0325","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0720-048X(02)00098-0","article-title":"Transrectal ultrasound color Doppler in the evaluation of recurrence of anal canal cancer","volume":"47","author":"Drudi","year":"2003","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0330","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s11605-009-0870-2","article-title":"Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging","volume":"13","author":"Otto","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.canrad.2015.06.011_bib0335","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/DCR.0000000000000291","article-title":"Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer?","volume":"58","author":"Peterson","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.canrad.2015.06.011_bib0340","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/DCR.0b013e318197d73e","article-title":"Interobserver and intraobserver variation of two-dimensional and three-dimensional anal endosonography in the evaluation of recurrent anal cancer","volume":"52","author":"Christensen","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.canrad.2015.06.011_bib0345","doi-asserted-by":"crossref","first-page":"W335","DOI":"10.2214\/AJR.11.8027","article-title":"Imaging of anal carcinoma","volume":"199","author":"Kochhar","year":"2012","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0350","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0009-9260(05)81444-8","article-title":"Magnetic resonance imaging with gadolinium-DTPA for assessment of bladder carcinoma and its response to treatment","volume":"47","author":"Hawnaur","year":"1993","journal-title":"Clin Radiol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0355","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s10350-005-0098-5","article-title":"Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101\u00a0patients","volume":"48","author":"Grabenbauer","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.canrad.2015.06.011_bib0360","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.ijrobp.2005.05.047","article-title":"Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer","volume":"63","author":"Chapet","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.06.011_bib0365","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2009.08.055","article-title":"Magnetic resonance imaging assessment of squamous cell carcinoma of the anal canal before and after chemoradiation: can MRI predict for eventual clinical outcome?","volume":"78","author":"Goh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.06.011_bib0370","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.crad.2005.05.008","article-title":"Magnetic resonance imaging of anal cancer","volume":"60","author":"Roach","year":"2005","journal-title":"Clin Radiol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0375","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1053\/crad.2002.0933","article-title":"Recurrent or residual pelvic bowel cancer: accuracy of MRI local extent before salvage surgery","volume":"57","author":"Robinson","year":"2002","journal-title":"Clin Radiol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0380","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/AJR.13.12256","article-title":"FDG PET\/CT in the management of colorectal and anal cancers","volume":"203","author":"Agarwal","year":"2014","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/196068","article-title":"Diagnostic performance of positron emission tomography\/computed tomography using fluorine-18\u00a0fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis","volume":"2014","author":"Caldarella","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.canrad.2015.06.011_bib0390","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2008.04.003","article-title":"Assessing the impact of FDG-PET in the management of anal cancer","volume":"87","author":"Nguyen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0395","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","article-title":"Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer","volume":"71","author":"Schwarz","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0400","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/bjc.2011.274","article-title":"FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy","volume":"105","author":"Day","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2015.06.011_bib0405","doi-asserted-by":"crossref","first-page":"449","DOI":"10.6004\/jnccn.2012.0046","article-title":"Anal carcinoma. Version 2.2012: featured updates to the NCCN guidelines","volume":"10","author":"Benson","year":"2012","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"10.1016\/j.canrad.2015.06.011_bib0410","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02049985","article-title":"Assessment of \u201csquamous cell carcinoma antigen\u201d (SCC) as a marker of epidermoid carcinoma of the anal canal","volume":"34","author":"Fontana","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.canrad.2015.06.011_bib0415","first-page":"275","article-title":"CEA, TPA, CA\u00a019-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors","volume":"82","author":"Indinnimeo","year":"1997","journal-title":"Int Surg"},{"key":"10.1016\/j.canrad.2015.06.011_bib0420","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.bjc.6605984","article-title":"Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review","volume":"103","author":"Lampejo","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2015.06.011_bib0425","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1179\/joc.1997.9.2.121","article-title":"Anal canal cancer diagnosis: usefulness of serum tumor markers","volume":"9","author":"Indinnimeo","year":"1997","journal-title":"J Chemother Florence Italy"},{"key":"10.1016\/j.canrad.2015.06.011_bib0430","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canrad.2015.06.011_bib0435","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.25671","article-title":"Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study","volume":"129","author":"Abramowitz","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canrad.2015.06.011_bib0440","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clindermatol.2013.10.006","article-title":"Human papillomavirus \u2013 associated diseases","volume":"32","author":"Grce","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.canrad.2015.06.011_bib0445","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jcv.2011.03.003","article-title":"Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France \u2013 The EDiTH VI study","volume":"51","author":"St Guily","year":"2011","journal-title":"J Clin Virol"},{"year":"2010","series-title":"Recommandations pour le d\u00e9pistage du cancer du col ut\u00e9rin (synth\u00e8se des recommandations en sant\u00e9 publique)","author":"Anon","key":"10.1016\/j.canrad.2015.06.011_bib0225"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181500164X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181500164X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:25:12Z","timestamp":1761135912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181500164X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":45,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S127832181500164X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2015.06.011","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suivi apr\u00e8s radioth\u00e9rapie d\u2019un cancer du canal anal","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2015.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}